Skip to main content
SupplementScience

Benefits of Strontium

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Fracture reduction — the SOTI trial (Meunier et al., 2004, n=1,649) found strontium ranelate 2g/day reduced vertebral fractures by 41% over 3 years in postmenopausal women with osteoporosis
  • Bone density increase — the TROPOS trial (Reginster et al., 2005, n=5,091) showed strontium ranelate reduced non-vertebral fractures by 16% and hip fractures by 36% in high-risk elderly women over 3 years
  • Dual mechanism — strontium uniquely both stimulates osteoblast-mediated bone formation and inhibits osteoclast-mediated bone resorption, unlike most osteoporosis drugs which only reduce resorption
  • Bone quality — strontium incorporates into hydroxyapatite crystals in bone, potentially improving bone mechanical strength
  • OTC availability — strontium citrate provides the same elemental strontium as prescription forms without requiring a prescription

What the Research Says

Strontium has the strongest evidence of any trace mineral for bone health, but primarily for the prescription ranelate form. The SOTI trial (Meunier et al., 2004, n=1,649) and TROPOS trial (Reginster et al., 2005, n=5,091) demonstrated significant vertebral and non-vertebral fracture reduction with strontium ranelate in postmenopausal osteoporosis. However, post-marketing surveillance revealed increased cardiovascular events, leading the EMA to restrict its use to severe osteoporosis in patients without cardiovascular risk factors. OTC strontium citrate has not been studied in large RCTs, but shares the same active element. An important caveat: strontium artificially inflates DEXA scan readings by approximately 10% due to its higher atomic number, meaning some of the apparent BMD increase is measurement artifact.

Related Conditions

OsteoarthritisJoint Pain
Full Strontium Guide

References

  1. (). The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New England Journal of Medicine. DOI
  2. (). Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. Journal of Clinical Endocrinology & Metabolism. DOI
  3. (). Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporosis International. DOI